How to give Amikacin and Gentamicin in UTI
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have excellent, comprehensive data from multiple authoritative textbooks. Let me compile the full answer.
Amikacin and Gentamicin in UTI - Clinical Dosing Guide
Both drugs are aminoglycosides - concentration-dependent antibiotics with a significant post-antibiotic effect. In UTI, they are not first-line agents but are important for complicated UTIs, Pseudomonas/gram-negative infections, MDR organisms, and when other agents fail or are contraindicated.
When Are They Used in UTI?
| Indication | Role |
|---|---|
| Complicated UTI / Pyelonephritis | Alternative to fluoroquinolones/cephalosporins |
| P. aeruginosa UTI | Aminoglycosides are agents of choice (excellent urinary concentration) |
| MDR gram-negative UTI | Amikacin preferred (most resistant to enzymatic inactivation) |
| Cystitis (uncomplicated) | Single-dose aminoglycoside is an acceptable alternative |
| Periprocedural (urologic surgery) | Gentamicin used as perioperative prophylaxis IV |
| Neonatal UTI/sepsis | Amikacin often preferred |
Aminoglycosides have a pharmacological advantage in UTI specifically because they achieve excellent concentrations in the urinary tract. - Goldman-Cecil Medicine, UTI section
Dosing
Once-Daily (Extended-Interval) Dosing - PREFERRED
This is the standard of care for most patients. It exploits:
- Concentration-dependent killing - higher peaks = faster, more complete bacterial killing
- Post-antibiotic effect - bactericidal activity persists even after drug falls below MIC (can last several hours)
- Reduced nephrotoxicity and ototoxicity - longer sub-threshold trough periods reduce drug accumulation in the kidney and inner ear
| Drug | Once-Daily Dose | Notes |
|---|---|---|
| Gentamicin | 5-7 mg/kg IV/IM once daily | For CrCl >60 mL/min |
| Amikacin | 15 mg/kg IV/IM once daily | Standard; up to 15-20 mg/kg for Pseudomonas/severe infections |
- Katzung, 16th Ed. - "If CrCl >60 mL/min, a single daily dose of 5-7 mg/kg of gentamicin or tobramycin (15 mg/kg for amikacin) is recommended"
- Goodman & Gilman - "Typical doses for high-dose, extended-interval strategies are 5 to 7 mg/kg for gentamicin and 15 to 25 mg/kg for amikacin every 24 h"
Traditional Divided Dosing (used in select populations)
| Drug | Divided Dose | Interval |
|---|---|---|
| Gentamicin | 1.7-2 mg/kg | Every 8 hours |
| Amikacin | 7.5 mg/kg | Every 8-12 hours |
Traditional divided dosing is now less preferred except in: pregnancy, neonates, pediatric patients, endocarditis combination therapy, and severe renal impairment (CrCl <25 mL/min, where every-36h or every-48h extended schedules may be needed).
Route of Administration
- IV infusion: Administer over 30-60 minutes (never as a rapid IV bolus - risk of neuromuscular blockade)
- IM: Acceptable; peak blood levels achieved within 30-90 minutes, identical to IV peak
- NOT oral: Aminoglycosides are very poorly absorbed from the GI tract
Specific UTI Scenarios (Harrison's Table 170-2)
| Infection type | Regimen |
|---|---|
| UTI (P. aeruginosa, complicated) | Any aminoglycoside - total daily dose given once daily |
| Pyelonephritis (severe, P. aeruginosa) | Amikacin 15 mg/kg/24h IV; treat 7-14 days (up to 2 weeks for severe) |
| Renal abscess | Drain if ≥3 cm + antibiotics for 4-6 weeks |
| Single-dose cystitis | Amikacin 15 mg/kg as a single dose (one-time treatment) - Goldman-Cecil |
Monitoring (Critical)
Aminoglycosides have a narrow therapeutic index. Monitoring is mandatory:
| Parameter | Target (Once-Daily) | Target (Divided Dose) |
|---|---|---|
| Peak level (gentamicin) | 15-20 mcg/mL | 5-10 mcg/mL |
| Trough level (gentamicin) | <1 mcg/mL (drawn at 18-24h) | <2 mcg/mL |
| Amikacin trough | <4-5 mcg/mL | <10 mcg/mL |
| Serum creatinine | Check at baseline + every 2-3 days | Same |
| Urine output | Monitor daily | Same |
For once-daily dosing, the Hartford nomogram is commonly used to check a 6-14 hour level and guide interval adjustments.
Toxicity to Watch For
| Toxicity | Details |
|---|---|
| Nephrotoxicity | Most common; reversible on stopping; risk higher with prolonged use, high troughs, concurrent nephrotoxins (NSAIDs, contrast, vancomycin) |
| Ototoxicity | Cochlear (high-frequency hearing loss) > vestibular; may be irreversible; risk with prolonged use |
| Neuromuscular blockade | Rare; avoid rapid IV bolus; caution with neuromuscular blocking agents and myasthenia gravis |
Renal Dose Adjustment
The half-life of aminoglycosides increases from the normal 2-3 hours up to 24-48 hours in significant renal impairment. Dose adjustment is essential:
- CrCl >60 mL/min: standard once-daily dosing as above
- CrCl 40-60: extend interval to every 36h or reduce dose
- CrCl <25: avoid extended-interval dosing; use conventional divided doses with close TDM, or avoid if possible
- Hemodialysis: only 40-60% of gentamicin removed per session; dose after each dialysis session
Key Points
- Amikacin is preferred over gentamicin when gram-negative resistance is a concern - it is the least affected by aminoglycoside-modifying enzymes and has broader coverage against MDR organisms
- Once-daily dosing is preferred for most UTI indications (better PK/PD, less toxicity)
- Aminoglycosides are not active against anaerobes or streptococci when used alone - add a beta-lactam or vancomycin for synergy when needed
- Do not mix aminoglycosides with penicillins in the same IV solution - inactivation occurs in vitro; amikacin is least affected by this interaction
- In pregnancy and neonates: use divided dosing with careful TDM
Sources: Goldman-Cecil Medicine 2-vol Set; Harrison's Principles of Internal Medicine 22E (2025); Katzung's Basic & Clinical Pharmacology 16th Ed; Goodman & Gilman's Pharmacological Basis of Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.